IRVING, Texas, Sept. 17, 2024 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC), in conjunction with its fourth quarter earnings release for fiscal 2024, invites you to listen to its conference call that will be broadcast live over the Internet on Thursday, October 17, 2024, at 11:00 a.m. Eastern Time (10:00 a.m. Central) with Peter Matt, President and CEO, and Paul Lawrence, Senior Vice President & CFO. The teleconference will also be available via webcast. To access the webcast (in listen-only mode), ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Commercial Metals (CMC) , which belongs to the Zacks Steel - Producers industry. When looking at the last two reports, this manufacturer and recycler of steel and metal products has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 13.86%, on average, in the last two quarters. For the most recent quarter, Commercia ...

IRVING, Texas, Aug. 22, 2024 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) has earned recognition on TIME's inaugural list of America's Best Mid-Size Companies 2024. This prestigious award is presented by TIME and Statista Inc., the leading statistics portal and industry ranking provider. America's Best Mid-Size Companies 2024 were identified based on employee satisfaction, revenue growth and sustainability transparency for companies that operate in the United States and generated at least $100M in ...

The Zacks Steel Producers industry is buffeted by significant challenges as steel prices have experienced a sharp decline in the United States and globally this year. Soft demand in China amid economic slowdown is also a concern. However, improved demand in the automotive space and a resilient non-residential construction market augur well for the industry. Players from the space like POSCO Holdings Inc. (PKX) , ArcelorMittal S.A. (MT) and Commercial Metals Company (CMC) are worth a look despite near-term h ...

Barbara R. Smith to Retire as Executive Chairman Robert S. Wetherbee Appointed Chairman of the Board of Directors Vicki Avril-Groves to Retire from the Board of Directors Tandra Perkins Appointed to the Board of Directors IRVING, Texas, Aug. 2, 2024 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) ("CMC" or the "Company") today announced that Barbara R. Smith, the Executive Chairman of the Company's Board of Directors (the "Board"), will retire from such position and from the Board, effective August 31 ...

Group 1 - The article discusses the role of Ernest Hoffman as a Crypto and Market Reporter for Kitco News, highlighting his extensive experience in market news since 2007 [3] - It mentions Hoffman's background in establishing a broadcast division for CEP News in Montreal, which developed a fast web-based audio news service [3] - The article notes Hoffman's educational qualifications, including a Bachelor's degree in Journalism from Concordia University [3]

HUNTSVILLE, AL, July 18, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today announced the appointment of Dr. Srini Tenjarla as the new Senior Vice President of CMC (Chemistry, Manufacturing, and Controls) and Formulation. Dr. Tenjarla brings over 20 years of extensive experience in drug development to Serina. "We are thrilled to welcome Dr. Tenjarla to our team," s ...

Nose-to-Brain Drug Delivery Shows Promising Patient Safety and Therapeutic Benefit SARASOTA, FL, July 18, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider. Resyca is a joint venture ...

NEW YORK, June 26, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced it has reached alignment with the U.S. Food and Drug Administration (FDA) on the Chemistry, Manufacturing, and Controls (CMC) aspects of Brainstorm's Phase 3b clinical trial for NurOwn®, its investigational therapy for amyotrophic lateral sclerosis (ALS). "This in-person Type C meeting with the FDA was an important step ...

NOTE 8. DERIVATIVES The decrease in fair value of the Company's commodity derivatives reported within other noncurrent assets is primarily due to the decrease in the value of a significant input used to measure the fair value of the Company's Level 3 commodity derivatives at May 31, 2024 as compared to August 31, 2023. See Note 9, Fair Value, for further discussion of the measurement of the fair value of the Company's Level 3 commodity derivatives. | --- | --- | --- | --- | --- | --- | --- | --- | |-------- ...